BIONIME Rightest Blood Glucose Monitoring System | Diabetes
2012.01.18 GE Selects Bionime to Launch Innovative Diabetes Solutions
Bionime will offer innovative GE-branded clinical and home-based patient care products for the rapidly growing global diabetes population
2011.03.16 Bionime Corporation (4737) Signed Agreement with GE.
- Date of Event:March 16th, 2011 - Counterparty to the Contract: GE.
2010.01.30 Bionime has won the PTPA
SAN DIEGO - June 30th, 2010 – Bionime is excited to announce that it has been awarded the influential PTPA Media Inc’s Seal of Approval for excellence in family products.
2009.08.19 FDA Alerts and Notices
Bionmie RightestTM Series Do Not Use GDH-PQQ, the Enzyme that FDA Issued a Public Health Notification on Potentially Fatal Errors with Glucose Monitoring Technology
2008.11.16 Ypsomed AG
Ypsomed AG, Burgdorf acquires 10 % equity stake in Bionime Corp.
2008.11.06 Innovation Award
8 winners chosen from a pool of 39 candidates! Bionime RightestTMGM100 series acquires “Innovation Award” from Mediphar Taipei and becoming the
  Keep me signed in(Public or not to check the total pre-computer)  
    Forgot username Forgot Password